Liva Healthcare

Liva Healthcare

Hospitaler og sundhedspleje

Delivering better health outcomes through our evidence-based, digital-first lifestyle change platform.

Om os

Liva is a leading digital therapeutics company that advances digital-first delivery of behaviour change programmes to improve health outcomes globally, at scale. Our team of dedicated healthcare professionals create personalised change programmes to support people in their journey to prevent, manage and treat obesity, type-2 diabetes and prediabetes and other cardiometabolic conditions. The safety and efficacy of our digital therapeutic programmes are well-supported by extensive evidence from randomised controlled trials (RCTs) and other clinical studies. Liva’s innovative digital-first coaching platform integrates seamlessly into healthcare systems offering personalised clinical support to more than 50,000 patients. Founded in Denmark, we have expanded our reach across multiple geographies, marking our presence as a global force for advancing better health outcomes. Our collaborations with healthcare systems, including the NHS, as well as partnerships with some of the world’s largest life science companies and health insurers allow us to impact lives on a large scale. Liva is supported by a number of investors across Europe including MIG, Athos, Maj Invest, DHV and Verlinvest.

Branche
Hospitaler og sundhedspleje
Virksomhedsstørrelse
51-200 medarbejdere
Hovedkvarter
Copenhagen
Type
Privat
Grundlagt
2015
Specialer
Healthcare management, Technology, Diabetes, obesity, digital health, NHS, GP, chronic disease management , lifestyle and behaviour change, cardiometabolic condition management og hybrid digital platform

Beliggenheder

  • Primær

    Danneskiold-Samsøes Allé 41

    Copenhagen, 1434, DK

    Se ruten
  • 116 Baker Street

    London, UK W1U 6TS, GB

    Se ruten

Medarbejdere hos Liva Healthcare

Opdateringer

  • Se organisationssiden for Liva Healthcare, grafik

    7.839 følgere

    Digital healthcare has the potential to transform the UK healthcare system - making care more efficient, accessible, and personalised. However, there are significant barriers to its adoption. With the new UK government in place and a renewed focus on improving healthcare outcomes, it's crucial to identify and address these challenges.

At Liva Healthcare, we are committed to driving innovation in this space. We have recently launched our latest white paper on digital therapeutics and their potential to become crucial for healthcare systems to become more proactive, accessible, and prevention-focused. Click here to download the white paper: https://lnkd.in/eReKXYQH In the meantime, we want to hear from you: What do you see as the biggest barrier to adopting digital healthcare in the UK? #ukhealthcare #healthinnovation #nhs #futureofhealth #digitalhealth #healthcarepolicy #digitaltherapeutics #patientcare

    Dette indhold er ikke tilgængeligt her

    Få adgang til dette indhold og meget mere i LinkedIn-appen

  • Se organisationssiden for Liva Healthcare, grafik

    7.839 følgere

    Styrk det digitale sundhedstilbud til jeres borgere. Hos Liva arbejder vi for at forebygge og forbedre behandlingsforløb for borgere med kroniske sygdomme. Vi hjælper bl.a. kommuner med: 🔸 At nå ud til en større og bredere gruppe af borgere 🔸 At give vejledning præget af nærhed og høj kvalitet til alle uanset tid og sted 🔸 At give vejlederne et overskueligt overblik over borgernes forløb og resultater #sundhed #forebyggelse #kroniskesygdomme #livsstilssygdomme #overvægt #hjertekarsygdomme #diabetes #prædiabetes

    • Der er ingen alternativ tekst for dette billede
  • Se organisationssiden for Liva Healthcare, grafik

    7.839 følgere

    Could an injectable medication help stop prediabetes in its tracks? Eli Lilly - a pharmaceutical company that develops, manufactures, and sells prescription drugs - recently announced exciting results from the SURMOUNT-1 trial 3 year study, which examines whether Tirzapetide is a safe and effective medication for people with obesity and prediabetes to manage their weight and avoid progression to type 2 diabetes. This study, the longest yet on Tirzepatide, tracked more than 1,000 people with overweight or obesity and prediabetes over a three year period. Key findings from the study: 🔸 Those taking 15mg (maximum dose) Tirzapetide lost an average of 22.9% body weight (compared to 2.1% in the placebo group) 🔸 Weekly Tirzapetide injections significantly reduced the risk of progressing from prediabetes to type 2 diabetes by 94% in adults with prediabetes plus overweight or obesity. The ability of this drug to regulate both glucose and appetite, and contribute to significant weight loss, is an exciting development in reducing the burden of type 2 diabetes and obesity. At Liva Healthcare, we know that in addition to medication, long-term lifestyle changes are crucial in managing prediabetes and other chronic conditions. Our digital platform provides personalised behaviour change coaching to help people make sustainable healthy changes to their diet and lifestyle. Whether through medical interventions or lifestyle changes, or both in tandem, preventing diabetes starts with taking action. Read more about these important findings here: https://lnkd.in/e2tMVncQ If you’re interested in more insights into managing and preventing chronic conditions like type 2 diabetes, don’t miss our latest white paper - offering valuable evidence on how long-term lifestyle changes can support better health outcomes, and more. Download it for free here: https://lnkd.in/eReKXYQH #diabetesprevention #prediabetes #type2diabetes #T2D #weightmanagement #healthinnovation

    The Weight Loss Drug That Can Prevent Diabetes

    The Weight Loss Drug That Can Prevent Diabetes

    time.com

  • Se organisationssiden for Liva Healthcare, grafik

    7.839 følgere

    Could the future of healthcare be arriving sooner than we think? The UK government’s new Regulatory Innovation Office (RIO) is set to make waves by simplifying the pathway for new health technologies, speeding up approvals, and allowing innovations like digital health solutions to reach patients faster. This move aims to remove long-standing barriers in healthcare regulation, ensuring that advanced solutions can be integrated into the NHS and other care settings more swiftly. This is more than just a change in regulation; it's an opportunity to redefine healthcare delivery. With RIO’s support, Liva’s innovative, evidence-based approaches can integrate more seamlessly into NHS and other healthcare systems, allowing us to bring our tailored solutions to an even wider audience. This aligns perfectly with our mission to deliver personalised care that drives better patient outcomes and supports a healthier future for all. By reducing delays and enabling technologies like ours to integrate into existing healthcare frameworks, the RIO initiative is setting the stage for a more innovative, efficient, and patient-centric approach to healthcare delivery. Liva Healthcare is ready to embrace this opportunity and further our commitment to transforming the healthcare landscape. Learn more about the RIO initiative: https://lnkd.in/e9FPTuCd To see how Liva Healthcare is leading the way in digital therapeutics, download our latest white paper for free here: https://lnkd.in/eReKXYQH #healthcareinnovation #digitalhealth #RIO #digitaltherapeutics

    Game-changing tech to reach the public faster as dedicated new unit launched to curb red tape

    Game-changing tech to reach the public faster as dedicated new unit launched to curb red tape

    gov.uk

  • Liva Healthcare genopslog dette

    Se profil for Ben Mitchell, grafik

    Associate Partner, DGA Group

    Great to work on this white paper with the Liva Healthcare team 👇 Liva are behind some of the NHS and industry's most well used digital therapeutics (DTx), notably in diabetes, weight loss and cardiometabolic conditions. DTx sit right at the heart of the three 'shifts' DHSC are targeting in the 10-year plan: analogue > digital 📲 treatment > prevention 🏃♂️ hospital > community 🏘 Ben Lewis Sian Jarvis, CB, FRCGP(H) Stephen Hankinson

    Se organisationssiden for Liva Healthcare, grafik

    7.839 følgere

    Liva Healthcare’s white paper on digital therapeutics is now live! The UK government’s 2024 conference now underway, and healthcare is top of the agenda. With reports like Lord Darzi’s recent NHS Review emphasising the urgency of transforming our healthcare system, one thing is clear: innovation is no longer a choice - it's a necessity. At Liva Healthcare, we’ve been at the forefront of this transformation, using Digital Therapeutics (DTx) to change how chronic diseases like type 2 diabetes, heart disease, and obesity are managed. Our latest white paper, "A White Paper on Digital Therapeutics", explores how DTx can: 🔸 Improve patient outcomes with personalised, real-time care 🔸Reduce the burden on the NHS and healthcare systems globally 🔸 Provide life sciences companies with critical insights for research and development In a world where chronic conditions account for 70% of global deaths, the time to act is now. Discover how DTx can help reshape healthcare for the better. 👉 Download the white paper and see how we're pioneering a digital-first approach to revolutionise healthcare: https://lnkd.in/evNXJVAB

    Transforming Healthcare with Digital Therapeutics

    Transforming Healthcare with Digital Therapeutics

    livahealthcare.com

  • Se organisationssiden for Liva Healthcare, grafik

    7.839 følgere

    The NHS is in critical condition - so what is the path to recovery? In his latest NHS review, Lord Darzi presents a stark reality: stagnating patient care, growing public distrust, and an urgent need for systemic transformation. But he also offers a way forward — with prevention at the core of a healthier future for the UK. At Liva Healthcare, we believe in the power of Digital Therapeutics (DTx) to transform chronic disease management and support the NHS’s recovery. Our new white paper, launched just last week, explores how DTx can reduce the burden on the NHS, empower patients, and drive proactive, personalised healthcare at scale. It’s time for policy makers to embrace digital health innovation. Darzi's vision for prevention aligns perfectly with what we offer: scalable, data-driven solutions that improve patient outcomes and ease pressure on healthcare systems. Read Lord Darzi’s full take on the NHS in his article here: https://lnkd.in/eiUwSs2N 🔸 Click here to download Liva Healthcare’s new white paper to learn more about the role digital therapeutics could play in transforming the UK healthcare system: https://lnkd.in/eReKXYQH #digitalhealth #nhs #healthcareinnovation #prevention #labourconference2024 #healthreform #digitaltherapeutics

    My report on the NHS diagnosed its dire condition. Now here’s the cure | Ara Darzi

    My report on the NHS diagnosed its dire condition. Now here’s the cure | Ara Darzi

    theguardian.com

  • Se organisationssiden for Liva Healthcare, grafik

    7.839 følgere

    Liva Healthcare’s white paper is now live! Digital therapeutics (DTx) are transforming the way we manage and prevent chronic diseases. In our newly-released white paper, we explore how DTx can revolutionise healthcare systems by improving patient outcomes, lowering costs, and making care more accessible and personalised. Our white paper doesn’t just provide insights - it outlines key recommendations for accelerating the adoption of dtx across healthcare systems. These recommendations are designed to help policymakers, healthcare providers, and innovators break down the barriers to wider implementation of digital health solutions. From prioritising digital transformation to embedding DTx into clinical trials, these recommendations pave the way for more proactive, equitable, and cost-effective healthcare systems. Swipe through Liva Healthcare’s key recommendations below and download the full white paper here: https://lnkd.in/evNXJVAB #digitaltherapeutics #NHS #healthinnovation #chronicdiseasemanagement #dtxadoption #healthcareuk

  • Se organisationssiden for Liva Healthcare, grafik

    7.839 følgere

    Med en dedikation til forebyggelse og individuel tilpasning tilbyder Liva en digital sundhedsplatform, der revolutionerer måden, vi tænker og håndterer sundhedsindsatsen på. Vores platform bliver brugt af kommuner i hele landet med målet om at fremme borgerne egenomsorg og forbedre deres livskvalitet gennem forebyggelse, håndtering og behandling af kroniske tilstande. #sundhed #forebyggelse #kroniskesygdomme #livsstilssygdomme #overvægt #diabetes

    • Der er ingen alternativ tekst for dette billede
  • Se organisationssiden for Liva Healthcare, grafik

    7.839 følgere

    Liva Healthcare has just launched a brand new white paper of Digital Therapeutics, and it further emphasises that digital health coaching isn’t just a trend - it’s a game-changer for diabetes management. Our innovative digital health coaching programme is transforming the lives of diabetes patients. This Liva study highlights: 🔹 A 4.3% average weight reduction in just 7 months 🔹Sustained engagement driving long-term health improvements 🔹Scalable and cost-effective solutions for healthcare systems By combining personalised coaching with continuous digital support, we're making diabetes management more effective and accessible. Patients are achieving significant weight loss and better overall health, all while reducing the need for frequent in-person consultations. Dive into the full blog post to explore how our digital health interventions are paving the way for a new era of chronic disease management. Discover the evidence behind our approach and see how Liva Healthcare is leading the charge in healthcare innovation. Curious to learn more? Click here to download our comprehensive white paper on the huge potential of digital therapeutics: https://lnkd.in/evNXJVAB #digitalhealth #healthtech #weightlossjourney #healthcareinnovation #digitaltherapeutics

    Unlocking better health: the impact of digital health coaching for diabetes management

    Unlocking better health: the impact of digital health coaching for diabetes management

    Liva Healthcare på LinkedIn

Tilsvarende sider

Finansiering

Liva Healthcare 5 runder i alt

Seneste runde

Serie B

30.229.187,00 US$

Læs mere på crunchbase